期刊文献+

ICU产超广谱β-内酰胺酶细菌医院感染危险因素与护理措施 被引量:4

Dangerous factors and nursing countermeasure of hospital infection of extend-spectrnm β-lactamase bacterium in ICU
下载PDF
导出
摘要 目的总结ICU产超广谱β-内酰胺酶细菌医院感染的危险因素,为预防与控制产超广谱β-内酰胺酶细菌流行提供护理依据。方法将ICU的28例产超广谱β-内酰胺酶细菌感染病例作为观察组,随机抽取同一时期、同病房、同基础疾病28例产超广谱β-内酰胺酶菌阴性病例作为对照组,分析产超广谱β-内酰胺酶细菌感染的相关危险因素。结果产超广谱β-内酰胺酶细菌医院感染与患者入住ICU时间长、多次住院、长期使用三代头孢、侵入性操作等因素有关。结论切断病原菌传播途径、缩短患者在ICU的天数、严格控制广谱抗生素应用,是预防产超广谱β-内酰胺酶细菌感染的重要措施。 Objective To discuss the dangerous factors of hospital infection of extend- spectrnm β- lactamase bacterium in ICU in order to provide basis for preventing and controlling the prevalence of the bactetia. Method Correlative dangerous factors were investigated and analyzed in ICU patients. 28 patients with hospital infection of extend - spectrnm β - lactarnase bacterium were in observation group and 28 patient were randomly selected in the same ICU. Result Infection was related to the following factors: time in ICU, repeating hospitalization, long time using of third- generation cephalosporins, invasive operation and so on. Conclusion Stopping forms of transmition reducing time in ICU and controlling the using of antibiotics are the important measures of preventing the prevalence of extend- spectrnm β- lactamase bacterium.
机构地区 宁波市第二医院
出处 《护理与康复》 2006年第4期246-247,共2页 Journal of Nursing and Rehabilitation
基金 宁波市医学科研项目 编号:2005-28
关键词 ICU 产超广谱Β-内酰胺酶细菌 医院感染 护理对策 intensive care unit extend- spectrnm β- lactamase bacterium hospital infection nursing strategies
  • 相关文献

参考文献4

二级参考文献32

  • 1[2]Pena C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit[J]. J Hosp Infect,1997,35:9-16
  • 2[3]Quinn JP. Clinical significance of extended-spectrum beta-lactamases[J]. Eur J Clin Microbiol Infect Dis, 1994, 13 ( Suppl 1 ):S39-42
  • 3[4]Saurina G, Quale JM, Manikal VM,et al. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns[J]. J Antimicrob Chemother,2000,45:895-898
  • 4[5]Piroth L, Aube H, Doise JM, et al. Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. are betalactamase inhibitors of therapeutic value? [J] Clin Infect Dis,1998,27:76-80
  • 5[6]Amyes SG, Miles RS. Extended-spectrum beta-lactamases: the role of inhibitors in therapy[J]. J Antimicrob Chemother, 1998,42:415-417
  • 6[7]Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidimeresistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation[J]. J Infect Dis, 1996,174 : 529-536
  • 7[8]Patterson JE, Hardin TC, Kelly CA,et al. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae[J]. Infect Control Hosp Epidemiol, 2000,21:455-458
  • 8[1]Valero Juan LF, Campos R M, Saenz M C, et al. The incidence of nosocomial infection in the Intensive Care Unit[J]. Rev Clin Esp, 1996, 196(5): 281-290.
  • 9[2]Rozaidi S W, Sukra J, dan A. The incidence of nosocomial infection in the Intensive Care Unit[J]. Med J Malaysia, 2001, 56(2): 207-222.
  • 10[3]Luzzati R, Antozzi L, Bellocco R, et al. Prevalence of nosocomial infections in Intensive Care Units in Triveneto area, Italy[J]. Minerva Anestesiol, 2001, 67(9): 647-652.

共引文献67

同被引文献38

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部